NO921969L - Ikke-replikerende rekombinant fremstilte retroviruspartikler brukt som antivirale midler og immunogener - Google Patents

Ikke-replikerende rekombinant fremstilte retroviruspartikler brukt som antivirale midler og immunogener

Info

Publication number
NO921969L
NO921969L NO92921969A NO921969A NO921969L NO 921969 L NO921969 L NO 921969L NO 92921969 A NO92921969 A NO 92921969A NO 921969 A NO921969 A NO 921969A NO 921969 L NO921969 L NO 921969L
Authority
NO
Norway
Prior art keywords
hiv
particles
recombinant
produced
retroviral
Prior art date
Application number
NO92921969A
Other languages
English (en)
Norwegian (no)
Other versions
NO921969D0 (no
Inventor
Omar K Haffar
Shiu-Lok Hu
Allen W Senear
Bruce M Travis
Original Assignee
Oncogen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncogen filed Critical Oncogen
Publication of NO921969D0 publication Critical patent/NO921969D0/no
Publication of NO921969L publication Critical patent/NO921969L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO92921969A 1989-11-20 1992-05-19 Ikke-replikerende rekombinant fremstilte retroviruspartikler brukt som antivirale midler og immunogener NO921969L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43920589A 1989-11-20 1989-11-20
PCT/US1990/006798 WO1991007425A1 (en) 1989-11-20 1990-11-20 Non-replicating recombinant-made retroviral particles used as antiviral agents and immunogens

Publications (2)

Publication Number Publication Date
NO921969D0 NO921969D0 (no) 1992-05-19
NO921969L true NO921969L (no) 1992-06-26

Family

ID=23743729

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92921969A NO921969L (no) 1989-11-20 1992-05-19 Ikke-replikerende rekombinant fremstilte retroviruspartikler brukt som antivirale midler og immunogener

Country Status (14)

Country Link
EP (1) EP0502105A4 (el)
JP (1) JPH05503629A (el)
KR (1) KR920703639A (el)
AU (1) AU636944B2 (el)
CA (1) CA2068713A1 (el)
ES (1) ES2052478T1 (el)
FI (1) FI922277A (el)
GR (1) GR930300005T1 (el)
HU (1) HUT60506A (el)
NO (1) NO921969L (el)
OA (1) OA09698A (el)
TW (1) TW216446B (el)
WO (1) WO1991007425A1 (el)
ZA (1) ZA909302B (el)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0431128B1 (en) * 1989-06-01 2003-03-26 Applied Biotechnology, Inc. Vector coding for self-assembled, defective, non-self-propagating viral particles
US5861282A (en) * 1989-10-16 1999-01-19 Whitehead Institute For Biomedical Research Non-infectious HIV particles and uses therefor
WO1991019803A1 (en) * 1990-06-19 1991-12-26 Applied Biotechnology, Incorporated Self assembled, defective, nonself-propagating viral particles
DE4124817A1 (de) * 1991-07-26 1993-01-28 Basf Ag Waessrige polymerisatdispersionen
WO1993009238A1 (en) * 1991-11-08 1993-05-13 The Upjohn Company Feline leukemia virus vaccines
WO1993020840A1 (en) * 1992-04-14 1993-10-28 British Bio-Technology Limited Induction of ctl responses
US7001759B1 (en) 1993-01-26 2006-02-21 The Trustees Of The University Of Pennsylvania Compositions and methods for delivery of genetic material
ATE420193T1 (de) 1993-01-26 2009-01-15 Univ Pennsylvania Zusammensetzung zur verabreichung genetischen materials
DE69434469T2 (de) 1993-01-26 2006-06-14 Univ Pennsylvania Zusammensetzungen und verfahren zur verabreichung von genetischem material
GB9304239D0 (en) * 1993-03-01 1993-04-21 British Bio Technology Viral particles
US5955342A (en) * 1994-08-15 1999-09-21 Connaught Laboratories Limited Non-infectious, replication-defective, self-assembling HIV-1 viral particles containing antigenic markers in the gag coding region
US6291157B1 (en) 1998-02-23 2001-09-18 Connaught Laboratories Limited Antigenically-marked non-infectious retrovirus-like particles
US5858838A (en) 1998-02-23 1999-01-12 Taiwan Semiconductor Manufacturing Company, Ltd. Method for increasing DRAM capacitance via use of a roughened surface bottom capacitor plate
US6080408A (en) 1994-08-22 2000-06-27 Connaught Laboratories Limited Human immunodeficiency virus type 1 nucleic acids devoid of long terminal repeats capable of encoding for non-infectious, immunogenic, retrovirus-like particles
EP0817854A2 (en) * 1995-03-31 1998-01-14 Wolf, Hans, Prof. Dr. Antigen presentation system based on retrovirus-like particles
US6013506A (en) * 1995-06-05 2000-01-11 Wardley; Richard C. Feline leukemia virus vaccines
US6121021A (en) * 1997-12-16 2000-09-19 Connaught Laboratories Limited Constitutive expression of non-infectious HIV-like particles
PT1141315E (pt) 1998-12-31 2008-05-05 Novartis Vaccines & Diagnostic Polipéptidos do envelope (env) de hiv modificados
CA2358385C (en) 1998-12-31 2013-08-06 Chiron Corporation Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
AU1194802A (en) 2000-03-02 2001-12-11 Univ Emory DNA expression vectors and methods of use
US8623379B2 (en) 2000-03-02 2014-01-07 Emory University Compositions and methods for generating an immune response
AU2002252199B2 (en) 2001-03-08 2008-01-03 Emory University MVA expressing modified HIV envelope, GAG, and POL genes
EP1411770A4 (en) 2001-07-05 2006-05-10 Chiron Corp POLYNUCLEOTIDES CODING FOR ANTIGENIC C-TYPE HIV POLYPEPTIDES, POLYPEPTIDES AND THEIR USE
US20030170614A1 (en) 2001-08-31 2003-09-11 Megede Jan Zur Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof
AP2013007166A0 (en) 2011-04-06 2013-10-31 Univ Paris Descartes Inst De Rech Pour Le Dev Ird Pharmaceutical compositions for preventing and/or treating an HIV disease in humans
MA42502A (fr) 2015-07-21 2018-05-30 Modernatx Inc Vaccins contre une maladie infectieuse
US11045540B2 (en) 2017-03-15 2021-06-29 Modernatx, Inc. Varicella zoster virus (VZV) vaccine
US11752206B2 (en) 2017-03-15 2023-09-12 Modernatx, Inc. Herpes simplex virus vaccine
EP3938379A4 (en) * 2019-03-15 2023-02-22 ModernaTX, Inc. HIV RNA VACCINE

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4752565A (en) * 1986-04-07 1988-06-21 The United States Of America As Represented By The Department Of Health And Human Services Cell line producing AIDS viral antigens without producing infectious virus particles
JPH02203783A (ja) * 1989-02-02 1990-08-13 Banyu Pharmaceut Co Ltd 抗原性を有する非感染性エイズウイルス産生クローン化ヒトｔ細胞
JP3140757B2 (ja) * 1989-02-06 2001-03-05 デイナ・フアーバー・キヤンサー・インステイテユート パッケージング欠陥ｈｉｖプロウイルス、細胞系及びその使用
GB8923123D0 (en) * 1989-10-13 1989-11-29 Connaught Lab A vaccine for human immunodeficiency virus
CA2067778A1 (en) * 1989-10-16 1991-04-17 The Whitehead Institute For Biomedical Research Non-infectious hiv-1 particles and uses therefor

Also Published As

Publication number Publication date
WO1991007425A1 (en) 1991-05-30
TW216446B (el) 1993-11-21
KR920703639A (ko) 1992-12-18
EP0502105A4 (en) 1993-02-24
AU6905591A (en) 1991-06-13
JPH05503629A (ja) 1993-06-17
FI922277A0 (fi) 1992-05-19
AU636944B2 (en) 1993-05-13
CA2068713A1 (en) 1991-05-21
FI922277A (fi) 1992-05-19
EP0502105A1 (en) 1992-09-09
ES2052478T1 (es) 1994-07-16
HU9201659D0 (en) 1992-08-28
ZA909302B (en) 1991-09-25
HUT60506A (en) 1992-09-28
OA09698A (en) 1993-08-30
NO921969D0 (no) 1992-05-19
GR930300005T1 (el) 1993-04-28

Similar Documents

Publication Publication Date Title
NO921969L (no) Ikke-replikerende rekombinant fremstilte retroviruspartikler brukt som antivirale midler og immunogener
DK33190A (da) Hiv-3 retrovirus og anvendelse heraf
Pinter et al. Oligomeric structure of gp41, the transmembrane protein of human immunodeficiency virus type 1
Gallaher Detection of a fusion peptide sequence in the transmembrane protein of human immunodeficiency virus
Haigwood et al. Importance of hypervariable regions of HIV-1 gp120 in the generation of virus neutralizing antibodies
Myers et al. Evolutionary potential of complex retroviruses
NO863803L (no) Vaksiner og immunoanalyser for ervervet immunsviktsyndrom (aids).
WO1999027958A3 (en) Hiv-1 tat, or derivatives thereof for prophylactic and therapeutic vaccination
ES2140380T3 (es) Secuencias de adn que codifican polipeptidos gag retroviricos modificados y vacunas que las contienen o agregados de las mismas.
CA2230925A1 (en) Fusion protein delivery system and uses thereof
DE60026199T2 (de) Synthetische Gene für gagpol und deren Verwendungen
De Rossi et al. Synthetic peptides from the principal neutralizing domain of human immunodeficiency virus type 1 (HIV-1) enhance HIV-1 infection through a CD4-dependent mechanism
JP2004509601A5 (el)
SE9903031D0 (sv) Peptide mixture and vaccine against a chronic viral infection
MY104530A (en) Nonreplicating recombinant-made retroviral particles useful as anti-viral agents and as immunogens for pro- phylaxis and therapy against human retroviruses.
AU630861B2 (en) Recombinant hiv-2 polypeptides
SE8701628D0 (sv) Medel for analys mm
WO1993005812A1 (en) Method to induce cytotoxic t lymphocytes specific for a broad array of hiv-1 isolates using hybrid synthetic peptides
EP0327180A3 (en) Vaccine containing polypeptides derived from the envelope gene of human immunodeficiency virus type 1
Ball et al. EIAV genomic organization: further characterization by sequencing of purified glycoproteins and cDNA
Soutschek et al. Purification of a recombinantly produced transmembrane protein (gp41) of HIV I
AP9901615A0 (en) Multiple branch peptide constructions.
Vogt et al. Heterologous HIV-2 challenge of rhesus monkeys immunized with recombinant vaccinia viruses and purified recombinant HIV-2 proteins
AU8976691A (en) Selected peptides of the group-specific antigen (gag) of human immunodeficiency virus (hiv), the preparation and use thereof
WO2022035860A3 (en) Replication-competent adenovirus type 4-hiv env vaccines and their use